SOLV Company Profile and Key Details

NYSE : SOLV

Solventum

$78.07

-0.05-0.06%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Solventum Corporation (SOLV) stock declined over -0.06%, trading at $78.07 on NYSE, down from the previous close of $78.12. The stock opened at $77.39, fluctuating between $76.90 and $78.36 in the recent session.

Stock Snapshot

78.12

Prev. Close

13.54B

Market Cap

76.9

Day Low

8.96

P/E Ratio

8.71

EPS (TTM)

N/A

Cash Flow per Share

77.39

Open

173.45M

Number of Shares

78.36

Day High

85.05%

Free Float in %

N/A

Book Value

631.77K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 09, 2026	77.49	78.36	76.90	78.07	818.65K
Feb 06, 2026	76.86	78.35	76.66	78.12	859.85K
Feb 05, 2026	76.70	77.60	76.41	76.98	1.06M
Feb 04, 2026	75.84	77.87	75.84	76.49	1.56M
Feb 03, 2026	76.50	78.33	75.17	75.75	1.12M
Feb 02, 2026	76.78	77.69	76.23	76.91	934.46K
Jan 30, 2026	76.13	76.99	75.59	76.97	1.34M
Jan 29, 2026	76.47	76.82	75.61	76.52	1.04M
Jan 28, 2026	77.08	77.35	76.39	76.60	1.21M
Jan 27, 2026	78.25	78.80	77.44	77.61	790.86K
Jan 26, 2026	80.13	81.04	78.93	79.01	797.25K
Jan 23, 2026	79.85	80.32	78.77	78.91	597.64K
Jan 22, 2026	80.44	81.22	80.04	80.26	520.06K
Jan 21, 2026	79.39	81.03	79.12	80.37	694.91K
Jan 20, 2026	79.56	81.75	78.56	78.96	988.52K
Jan 16, 2026	80.08	80.70	79.48	79.48	805.41K
Jan 15, 2026	80.34	81.00	79.71	80.44	714.1K
Jan 14, 2026	79.43	80.68	79.43	80.05	1.03M
Jan 13, 2026	85.29	85.47	79.60	80.03	1.67M
Jan 12, 2026	86.00	86.14	84.84	85.69	772.98K

Contact Details

Maplewood, MN 55144

United States

https://www.solventum.com 651 733 1110

About Company

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Stock Peers

HCA

-4.15-0.83%

HCA Healthcare, Inc.$497.54 CHE

0.43+0.10%

Chemed Corporation$448.17 UHS

-5.62-2.57%

Universal Health Services, Inc.$212.94 THC

-8.41-4.18%

Tenet Healthcare Corporation$192.96 DVA

-3.19-2.27%

DaVita Inc.$137.64 EHC

0.77+0.73%

Encompass Health Corporation$106.16 USPH

-1.1-1.29%

U.S. Physical Therapy, Inc.$84.48 BKDT

-2.09-2.62%

Brookdale Senior Living Inc. 7.$77.60 SNDA

0.48+1.40%

Sonida Senior Living, Inc.$34.67 FMS

-0.19-0.79%

Fresenius Medical Care AG & Co. KGaA$23.89

Company Overview

Solventum Corporation (NYSE:SOLV) closed at $78.07 USD, losing -$0.05 (-0.06%) from the previous close of $78.12. The stock is currently mid-range between its 52-week high and low $60.70 and $88.20. With a market capitalization of about $13.54 billion, Solventum Corporation is classified as a large-cap and shows lower-than-market volatility (beta ~0.51). Key stats such as the average daily volume over the past year has been around 1.06 million shares, volume is running light vs its 52-week average. Headquartered in Maplewood, MN, Solventum Corporation operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Bryan C. Hanson, the company employs approximately 22,000 people and listed since April 01, 2024. Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -0.75%, SMA50 -3.53%, SMA200 4.25%). The stock’s 14-day RSI is 46.33 (neutral), while the ATR of 1.77 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -11.49% below its high and over 28.62% above its low. Average 10-day trading volume of 1.10 million shares is in line with the 3-month average of 1.02 million, indicating normal recent market interest.

Valuation Metrics

Solventum Corporation trades at a P/E ratio of 8.93, slightly below the S&P 500 average, with a price-to-sales ratio of 1.61 and a price-to-book ratio of 2.73 suggesting the stock is closer to book value. The P/FCF stands at 270.94, also above market averages.

Dividend & Fair Value

Solventum Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $255.53. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 0.99% annually over the next five years. Analyst sentiment is neutral. Analyst rating data shows there are 6 Strong Buy ratings, 2 Buy ratings, 10 Hold ratings, 1 Sell rating and 0 Strong Sell ratings. Price targets range from $105.00 to $71.00. The high target offers 34.49% upside. The low target suggests -9.06% downside. The mean target is $87.26. This offers 11.77% upside. Solventum Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 06, 2025, missed forecasts by 4.9%. The prior quarter beat by 16.55%. Over the last six quarters, Apple has recorded several small beats. These include 18.86% in August 08, 2024.

Shareholding & Insider Activity

Solventum Corporation has 173.39 million shares outstanding. The public float is 147.51 million shares, elevated short interest at 2.77% of float. This equals 3.85 million shares. The short ratio is 3.8 days. Institutional investors hold 85.19% of the float. Insiders own 14.91%. Over the past six months, insider transactions show net selling. They sold 8.80 million shares across 1 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Solventum has not generated any revenue.
On valuation metrics, Solventum trades at a P/E of 8.93, P/S of 1.61 and P/B of 2.73. The current ratio is 1.50 and quick ratio is 1.14. Operationally, the company’s inventory turnover is 3.64 and cash conversion cycle is 80.60 days. Debt-to-equity is 1.03, supported by a cash flow-to-debt ratio of 0.10.

Price Forecast & Outlook

Our AI price prediction model suggests that Solventum Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.53%, with price expected at $74.53 by February 23, 2026, within a range of $72.59 to $76.43 3-Month Outlook: Projected rise of 37.07%, reaching $107.01 by May 07, 2026, with a range of $105.25 to $109.34. 1-Year Outlook: Projected gain of 20.03%, with price at $93.71 by February 09, 2027, within a range of $92.04 to $95.02.

Key Takeaways

Solventum Corporation (NYSE:SOLV) shares are flat -0.35% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Solventum Corporation trading at a premium to the broader market with a P/E of 8.93. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $81.76, suggesting 4.73% upside. Our AI forecast model points to short-term weakness (-4.53% over two weeks), a medium-term rise (37.07% over three months), and a longer-term gain (20.03% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Solventum Corporation (SOLV) stock price?

Solventum Corporation (NYSE: SOLV) stock price is $78.07 in the last trading session. During the trading session, SOLV stock reached the peak price of $78.36 while $76.90 was the lowest point it dropped to. The percentage change in SOLV stock occurred in the recent session was -0.06% while the dollar amount for the price change in SOLV stock was - $0.05.

SOLV's industry and sector of operation?

The NYSE listed SOLV is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Solventum Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SOLV?

No Data

How SOLV did perform over past 52-week?

SOLV's closing price is 28.62% higher than its 52-week low of $60.70 where as its distance from 52-week high of $88.20 is -11.48%.

How many employees does SOLV have?

Number of SOLV employees currently stands at 22,000.

Link for SOLV official website?

Official Website of SOLV is: https://www.solventum.com

How do I contact SOLV?

SOLV could be contacted at phone 651 733 1110 and can also be accessed through its website. SOLV operates from 3M Center, Maplewood, MN 55144, United States.

How many shares of SOLV are traded daily?

SOLV stock volume for the day was 631.77K shares. The average number of SOLV shares traded daily for last 3 months was 1.06M.

What is the market cap of SOLV currently?

The market value of SOLV currently stands at $13.54B with its latest stock price at $78.07 and 173.45M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	22000
Beta	0.51
Sales or Revenue	N/A
5Y Sales Change%	0.124%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Care Facilities

SOLV Company Profile and Key Details

Solventum

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Company Overview

Earnings & Analyst Outlook

Key Takeaways

Price Forecast & Outlook

Valuation Metrics